NBTY sets price talk for $1.8bn debt amid levloan drought
NBTY, the US vitamins and nutritional supplements manufacturer owned by Carlyle, had bank meetings in London this morning for its $1.8bn refinancing package, with another scheduled for Monday in New York.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts